Plasma Phospholipid Trans ‐Fatty Acids Levels, Cardiovascular Diseases, and Total Mortality: The Cardiovascular Health Study
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Background: While self‐reported trans– fatty acid ( TFA ) consumption is linked to coronary heart disease ( CHD ), relationships between objective biomarkers of TFA subtypes ( t‐ 16:1n9, total t‐ 18:1, and cis / trans‐ ( c / t‐ ), t / c‐ and t / t‐ 18:2) and cardiovascular disease ( CVD ) or total mortality are not well established. Methods and Results: We evaluated 2742 adults in the Cardiovascular Health Study, aged 74±5 years and free of prevalent CVD , with plasma phospholipid TFA measures in 1992. Incident fatal and nonfatal CHD events, CVD and non‐ CVD mortality, and total mortality were centrally adjudicated through 2010. Risks were assessed using Cox proportional hazards. During 31 494 person‐years, 1735 total deaths and 639 total CHD events occurred. In the multivariate model including mutual adjustment for the 5 TFA subtypes, circulating t / t‐ 18:2 was associated with higher total mortality (extreme quintile hazard ratio ( HR )=1.23, 95% CI =1.04 to 1.44, P ‐trend=0.01), CVD mortality ( HR =1.40, 95% CI =1.05 to 1.86, P ‐trend=0.02), and total CHD ( HR =1.39, 95% CI =1.06 to 1.83, P ‐trend=0.01). t / c‐ 18:2 was positively related to total mortality ( HR =1.19, P ‐trend=0.05), total CHD ( HR =1.67, P ‐trend=0.002), and nonfatal CHD ( HR =2.06, P ‐trend=0.002) after mutual adjustment; these associations were insignificant without mutual adjustment. Neither t‐ 16:1n9 nor t‐ 18:1 was significantly associated with total mortality or CVD , nor was c / t ‐18:2 if we excluded early cases. Conclusions: Among circulating TFA s, t / t‐ 18:2 was most adversely associated with total mortality, mainly due to the increased risk of CVD . t / c‐ 18:2 was also positively associated with total mortality and CHD , but only after adjustment for other TFA s. These results highlight the need for further investigation of dietary sources, nondietary determinants, and health effects of specific TFA subtypes, especially t ‐18:2 isomers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baron, R. M., & Kenny, D. A. (1986) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.51.6.1173 · Cited by 91,532
Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811
(2007) · The Lancet · doi:10.1016/s0140-6736(07)61778-4 · Cited by 2,331 · cited 1×
“60 compare favorably to similar correlations over time for other common CVD risk factors such as blood pressure and cholesterol levels.(29,30) Conversely, the lower within-person reliability for t/c-18:2 would cause greater exposure misclassification over time and attenuation of true associations toward the null.”
Trans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · cited 1×
“The absence of association between circulating t-18:1 and CVD outcomes is puzzling, given that this fatty acid is the major contributor to total TFA consumption from PHVO, which has been consistently linked to adverse lipid effects in trials,(4,53) and elevated CHD risk when estimated from self-reported dietary questi…”
Self-citationInflammation as a risk factor for atrial fibrillation
Aviles, R. J., Martin, D. O., Apperson-Hansen, C., Houghtaling, P. L., Rautaharju, P., Kronmal, R. A., Tracy, R. P., Van Wagoner, D. R., Psaty, B. M., Lauer, M. S., et al. (2003) · Circulation · doi:10.1161/01.cir.0000103131.70301.4f · Cited by 1,425
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.
Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250601 · Cited by 1,163
Alcohol and coronary heart disease: a meta-analysis.
Corrao, G., Rubbiati, L., Bagnardi, V., Zambon, A., & Poikolainen, K. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.951015056.x · Cited by 875
Health effects of trans-fatty acids: experimental and observational evidence
Mozaffarian, D., Aro, A., & Willett, W. C. (2009) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602973 · Cited by 662
Self-citationTrans Fatty Acids and Coronary Heart Disease
Ascherio, A., Katan, M. B., Zock, P. L., Stampfer, M. J., & Willett, W. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906243402511 · Cited by 569
Baer, D. J., Judd, J. T., Clevidence, B. A., & Tracy, R. P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/79.6.969 · Cited by 476
Cited by
de Souza, R. J., Mente, A., Maroleanu, A., Cozma, A. I., Ha, V., Kishibe, T., Uleryk, E., Budylowski, P., Schünemann, H., Beyene, J., et al. (2015) · BMJ · doi:10.1136/bmj.h3978 · Cited by 1,424
Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association
Sacks, F. M., Lichtenstein, A. H., Wu, J. H. Y., Appel, L. J., Creager, M. A., Kris-Etherton, P. M., Miller, M., Rimm, E. B., Rudel, L. L., Robinson, J. G., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000510 · Cited by 1,386
Self-citationFunctional Roles of Fatty Acids and Their Effects on Human Health
Calder, P. C. (2015) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607115595980 · Cited by 1,160
Mozaffarian, D. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv595 · Cited by 40
Self-citation
Metadata
- Authors
- Wang, Q., Imamura, F., Lemaitre, R. N., Rimm, E. B., Wang, M., King, I. B., Song, X., Siscovick, D., & Mozaffarian, D.
- Venue
- Journal of the American Heart Association
- Published
- 2014-08-15
- Volume
- 3
- Issue
- 4
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2134283586
- Cited by
- 52
- References
- 14
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Plasma Phospholipid Trans ‐Fatty Acids Levels, Cardiovascular Diseases, and Total Mortality: The Cardiovascular Health Study. https://app.cochat.ai/papers/10.1161/jaha.114.000914
- The paper
- Wang, Q., Imamura, F., Lemaitre, R. N., Rimm, E. B., Wang, M., King, I. B., Song, X., Siscovick, D., & Mozaffarian, D. (2014). Plasma Phospholipid Trans ‐Fatty Acids Levels, Cardiovascular Diseases, and Total Mortality: The Cardiovascular Health Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.114.000914
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.